15:33 Dec 20
Beta Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Beta Drugs Ltd.
0/100 Not Eligible
Quality6/100 Expensive Valuation
Valuation67/100 Technically Moderately Bullish
TechnicalSWOT
Strength
5
Weakness
4
Opportunity
1
Threat
0
1.98K
Market Cap (Cr)
-
PE Ratio
12.61
Price to Book Ratio
44.27
RSI
12.32 %
Net Profit Margin
Rating Based on 1 Analysts
Buy
100%
Hold
0%
Sell
0%
Buy
Analyst Price Target
The average price target is 2245 with a high estimate of 2245 and low estimate of 2245
Current 2060.05
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
